» Authors » Julia E Kravchenko

Julia E Kravchenko

Explore the profile of Julia E Kravchenko including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 700
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mitkin N, Hook C, Schwartz A, Biswas S, Kochetkov D, Muratova A, et al.
Sci Rep . 2015 Mar; 5:9330. PMID: 25786345
Elevated expression of chemokine receptors in tumors has been reported in many instances and is related to a number of survival advantages for tumor cells including abnormal activation of prosurvival...
2.
Chumakov S, Kravchenko J, Prassolov V, Frolova E, Chumakov P
Plasmid . 2010 Jan; 63(3):143-9. PMID: 20064551
Gene silencing based on RNA interference is widely used in fundamental research and in practical applications. However, a commonly incomplete functional suppression represents a serious drawback of this technology. We...
3.
Olovnikov I, Kravchenko J, Chumakov P
Semin Cancer Biol . 2008 Dec; 19(1):32-41. PMID: 19101635
The p53 tumor suppressor plays pivotal role in the organism by supervising strict compliance of individual cells to needs of the whole organisms. It has been widely accepted that p53...
4.
Sablina A, Budanov A, Ilyinskaya G, Agapova L, Kravchenko J, Chumakov P
Nat Med . 2005 Nov; 11(12):1306-13. PMID: 16286925
It is widely accepted that the p53 tumor suppressor restricts abnormal cells by induction of growth arrest or by triggering apoptosis. Here we show that, in addition, p53 protects the...
5.
Kravchenko J, Rogozin I, Koonin E, Chumakov P
Nature . 2005 Aug; 436(7051):735-9. PMID: 16079853
Transcription of eukaryotic genes is performed by three nuclear RNA polymerases, of which RNA polymerase II is thought to be solely responsible for the synthesis of messenger RNAs. Here we...
6.
Rokhlin O, Taghiyev A, Guseva N, Glover R, Chumakov P, Kravchenko J, et al.
Oncogene . 2005 Jul; 24(45):6773-84. PMID: 16007156
It has been suggested in many studies that combined treatment with chemotherapeutic agents and apoptosis-inducing ligands belonging to TNFR family is a more effective strategy for cancer treatment. However, the...
7.
Pugacheva E, Ivanov A, Kravchenko J, Kopnin B, Levine A, Chumakov P
Oncogene . 2002 Jul; 21(30):4595-600. PMID: 12096336
Mutated forms of p53 are often expressed in a variety of human tumors. In addition to loss of function of the p53 tumor suppressor, mutant p53s contribute to malignant process...